Press release
Erythropoietin Drugs Market: A Growing Industry Poised to Reach $14.41 Billion by 2028 |
The global erythropoietin drugs market has experienced steady growth over the years, driven by the increasing prevalence of chronic kidney disease, cancer, and other conditions associated with anemia. Additionally, advancements in biotechnology and the development of novel EPO drugs have contributed to market expansion.
Biosimilars have emerged as a significant segment in the erythropoietin drugs market. Biosimilars are highly similar copies of already authorized EPO drugs. They offer a more affordable alternative to the expensive branded EPO drugs, promoting cost savings in healthcare systems.
North America and Europe have traditionally been the largest markets for erythropoietin drugs, owing to the high prevalence of chronic kidney disease and a well-established healthcare infrastructure. However, emerging economies in Asia-Pacific, such as China and India, are witnessing rapid growth in the market due to improving healthcare access and rising awareness about anemia treatment.
Request Sample Copy of Report: https://www.alliedmarketresearch.com/request-sample/59
Market Drivers:
Increasing Prevalence of Chronic Kidney Disease: Chronic kidney disease (CKD) is a significant driver of the erythropoietin drugs market. Anemia is a common complication of CKD, and erythropoietin drugs are extensively used to stimulate red blood cell production in these patients. As the prevalence of CKD continues to rise globally, the demand for erythropoietin drugs is expected to increase.
Rising Incidence of Cancer-Related Anemia: Cancer patients often experience anemia due to the effects of chemotherapy, radiation therapy, or the tumor itself. Erythropoietin drugs are commonly prescribed to manage anemia in cancer patients. With the increasing incidence of cancer worldwide, the demand for erythropoietin drugs in this patient population is expected to grow.
Market Segmentation:
Product Type:
a. Epoetin Alfa: It is the most widely used erythropoietin drug and includes both original branded products and biosimilars.
b. Darbepoetin Alfa: This is a modified form of erythropoietin that has a longer half-life and requires less frequent dosing compared to epoetin alfa.
Application:
a. Anemia Associated with Chronic Kidney Disease: Erythropoietin drugs are commonly prescribed to manage anemia in patients with chronic kidney disease.
b. Cancer-Related Anemia: Erythropoietin drugs are used to treat anemia in cancer patients undergoing chemotherapy or radiation therapy.
c. HIV/AIDS-Related Anemia: Erythropoietin drugs may be used to address anemia associated with HIV/AIDS and antiretroviral therapy.
Distribution Channel:
a. Hospitals and Clinics: Erythropoietin drugs are primarily administered in healthcare settings, including hospitals and clinics.
b. Retail Pharmacies: Some erythropoietin drugs may be available for purchase through retail pharmacies for self-administration or home care.
Geography:
a. North America: Includes the United States and Canada.
b. Europe: Includes countries such as Germany, France, UK, and Italy.
c. Asia-Pacific: Includes countries like China, Japan, India, and Australia.
d. Latin America: Includes countries in Central and South America.
e. Middle East and Africa: Includes countries in the Middle East and Africa region.
Brand vs. Biosimilar:
a. Branded Erythropoietin Drugs: These are original, patented products developed by pharmaceutical companies.
b. Biosimilar Erythropoietin Drugs: These are highly similar copies of already authorized erythropoietin drugs, offering a more affordable alternative.
It's important to note that the actual segmentation may vary depending on the specific research or analysis being conducted in the erythropoietin drugs market.
Request for Customization - https://www.alliedmarketresearch.com/request-for-customization/59
Competitive Landscape:
The global erythropoietin drugs market includes an in-depth analysis of the prime market players such as Johnson & Johnson, Amgen Inc., Roche, Hospira Inc., Biocon, LG Life Sciences Ltd., Teva Pharmaceutical Industries Ltd., Intas Pharmaceuticals, Ranbaxy Laboratories Ltd., and Celltrion, Inc.
Procure Complete Report at :
https://www.alliedmarketresearch.com/purchase-enquiry/59
Related Reports :
Consumer Healthcare Market https://www.alliedmarketresearch.com/consumer-healthcare-market
Cord Blood Banking Services Market https://www.alliedmarketresearch.com/cord-blood-banking-services-market
Nerve Repair and Regeneration Market https://www.alliedmarketresearch.com/nerve-repair-and-regeneration-market
Contact Details:
David Correa
USA/Canada (Toll-Free): +1-800-792-5285, +1-503-894-6022
help@alliedmarketresearch.com
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Erythropoietin Drugs Market: A Growing Industry Poised to Reach $14.41 Billion by 2028 | here
News-ID: 3247364 • Views: …
More Releases from Allied Market Research
Global Urinary Drainage Bags Market: Trends, Growth, and Insights to 2031
The global urinary drainage bags market is experiencing robust growth, with its market size valued at $1.4billion in 2021 and projected to reach $2billion by 2031. This expansion represents a compound annual growth rate (CAGR) of 3.8% from 2021 to 2031, highlighting the increasing demand for these essential medical devices.
Get a Sample Copy of this Report: https://www.alliedmarketresearch.com/request-sample/A17529
What Are Urinary Drainage Bags?
Urinary drainage bags are specialized medical devices designed to collect…
Cream Powder Market to Reach $8.9 Billion by 2031 with 6.4% CAGR
The global cream powder industry was estimated at $4.8 billion in 2021 and is expected to hit $8.9 billion by 2031, registering a CAGR of 6.4% from 2022 to 2031.
The cream powder market is experiencing growth due to various factors, including the increasing popularity of bakeries and HoReCa (hotels, restaurants, and cafes) and rising consumer demand for natural products. The dairy-based segment is a significant contributor to the market's growth…
Micro Drone Market Valued at $6.71 Billion in 2020, Expected to Reach $28.91 Bil …
The global micro drone industry generated $6.71 billion in 2020, and is expected to reach $28.91 billion in 2030, witnessing a CAGR of 17.2% from 2021 to 2030. The report provides an extensive analysis of changing market dynamics, top segments, top investment pockets, regional landscape, value chain, and competitive scenario.
Increased operational efficiency and rise in demand for improved surveillance drive the growth of the global micro drone market. However, strict…
Microwavable Foods Market to reach $230.93 billion by 2031, growing at a CAGR of …
The global microwaveable foods industry was accounted for $120.45 billion in 2020, and is expected to reach $230.93 billion by 2031, growing at a CAGR of 5.6% from 2022 to 2031.
Rise in popularity of fast-food restaurants and large population base coupled with increase in number of quick-service restaurants drive the global microwaveable foods market. However, lack of awareness about microwavable foods hinders the market growth. On the contrary, rise in…
More Releases for Erythropoietin
Erythropoietin (EPO) Drugs Market: An Overview
Introduction:
Erythropoietin (EPO) is a glycoprotein hormone that plays a crucial role in regulating red blood cell production (erythropoiesis) in the body. EPO drugs are synthetic versions of this hormone used to treat anemia, particularly in patients with chronic kidney disease (CKD), cancer, HIV, and other critical conditions that impact red blood cell production. EPO drugs help maintain adequate hemoglobin levels, improving the quality of life for patients by reducing the…
Erythropoietin Drugs Market Size, Opportunities 2022-2030
The Erythropoietin Drugs Market. The report delves into current trends, growth drivers, competitive landscape, and future forecasts, providing invaluable insights for stakeholders looking to understand the dynamics of this rapidly evolving sector. The global erythropoietin drugs market is poised for substantial growth, and the insights provided in this report are crucial for navigating this promising landscape.
-------------------------------------------------------------------------------------------------------------------
REQUEST A $1000 DISCOUNT ON CREDIT CARD PURCHASE: https://www.acumenresearchandconsulting.com/inquiry-before-buying/2675
-------------------------------------------------------------------------------------------------------------------
Market Overview:
The global erythropoietin drugs market was…
Erythropoietin Drugs Market - Revitalizing Lives: Erythropoietin Drugs for Enhan …
Newark, New Castle, USA: The "Erythropoietin Drugs Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Erythropoietin Drugs Market: https://www.growthplusreports.com/report/erythropoietin-drugs-market/8627
This latest report researches the industry structure, sales, revenue,…
Erythropoietin Market Size, Share, Development by 2023
New report published by Market Research Report Store (MRRS) which offers insights on the global Erythropoietin market.
Erythropoietin is produced by interstitial fibroblasts in the kidney in close association with peritubular capillary and proximal convoluted tubule. It is also produced in perisinusoidal cells in the liver. While liver production predominates in the fetal and perinatal period, renal production is predominant during adulthood.
Click to view the…
Erythropoietin Drugs Market
Erythropoietin alfa is widely used to treat anemia and increase the red blood cells count in the body. Erythropoietin drugs are developed in vitro by extracting the erythropoietin from the human body and developing it through the use of recombinant DNA technology. Erythropoietin drugs are also used to treat anemia induced from cancer, multiple myloma and HIV associated anemia. Recombinant DNA technology has allowed researchers to develop synthetic forms of…
European Erythropoietin Market Outlook 2022
ReportsWorldwide has announced the addition of a new report title European Erythropoietin Market Outlook 2022 to its growing collection of premium market research reports.
Erythropoietin drugs are protein therapeutics, which is used to treat various types of anaemia. These drugs play a significant role in treating CKD related anaemia and cancer related anaemia. Since its inception, the erythropoietin drugs market has witnessed various technological advancements, which have resulted in development of…
